Levofloxacin prophylaxis in patients with myeloma

Lancet Oncol. 2020 Feb;21(2):e67. doi: 10.1016/S1470-2045(19)30824-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibiotic Prophylaxis
  • Double-Blind Method
  • Febrile Neutropenia*
  • Humans
  • Levofloxacin
  • Multiple Myeloma*

Substances

  • Levofloxacin